Therapeutic Challenges for Cisplatin-Resistant Ovarian Germ Cell Tumors

The majority of patients with advanced ovarian germ cell cancer are treated by cisplatin-based chemotherapy. Despite adequate first-line treatment, nearly one third of patients relapse and almost half develop cisplatin-resistant disease, which is often fatal. The treatment of cisplatin-resistant dis...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Cancers (Basel)
Asıl Yazarlar: De Giorgi, Ugo, Casadei, Chiara, Bergamini, Alice, Attademo, Laura, Cormio, Gennaro, Lorusso, Domenica, Pignata, Sandro, Mangili, Giorgia
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: MDPI 2019
Konular:
Review
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC6826947/
https://ncbi.nlm.nih.gov/pubmed/31627378
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/cancers11101584
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller